Jul. 14 at 3:38 AM
$LUCD &
$PAVM This is the sorta rubbish that gets posted.
$5 Billion is a BIG NUMBER, so lets so how can you justify it as a MINIMUM.
Currently according to Lishan & Dennis LUCD does
$2M per half year (500 EsoGuard tests in the actual population at risk / covered CMS population per quarter) That has remained constant since the Q2 2025 CC where Lishan said it was a critical focus to target patients that would be covered under CMS's 12 month look back rule. All other tests are mass testing events for a fixed fee like Firefighters.
So Revenue of
$4M per year from CMS covered tests and a loss of
$50M+ per year, and being broke January 2027 as the baseline how do you get to
$5 Billion (MINIMUM🤡)
Using EXAS as a comparable from 12 years ago and not accepting that was BEFORE Wall Street had MULTIPLE diagnostic test launches that showed what was normal, what was good etc shows how desperate they are.
Ask them to justify ANY TARGET PRICE using compareables and they will STF UP. They CAN NOT
